About Nuclear factor interleukin-3-regulated protein
Nuclear factor interleukin-3-regulated protein (NFIL3) is a protein
from Homo sapiens identified by UniProt accession
Q16649, 462 residues long.
MolForge cross-references it against 0 known binders and
323 disease associations.
Target properties
| Protein name | Nuclear factor interleukin-3-regulated protein |
| UniProt accession | Q16649 |
| Gene | NFIL3 |
| Organism | Homo sapiens |
| Length | 462 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (323)
Diseases linked to this target (Open Targets).
- body mass index · score 0.48
- lean body mass · score 0.46
- body weight · score 0.43
- fat body mass · score 0.42
- body height · score 0.38
- bilirubin measurement · score 0.34
- neurofibrillary tangles measurement · score 0.31
- whole body water mass · score 0.30
- visceral adipose tissue measurement · score 0.30
- base metabolic rate measurement · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16649-F1 | alphafold | PREDICTED | 57.24 | — |
Amino-acid sequence (462 residues)
MQLRKMQTVK KEQASLDASS NVDKMMVLNS ALTEVSEDST TGEELLLSEG SVGKNKSSAC RRKREFIPDE KKDAMYWEKR RKNNEAAKRS REKRRLNDLV LENKLIALGE ENATLKAELL SLKLKFGLIS STAYAQEIQK LSNSTAVYFQ DYQTSKSNVS SFVDEHEPSM VSSSCISVIK HSPQSSLSDV SEVSSVEHTQ ESSVQGSCRS PENKFQIIKQ EPMELESYTR EPRDDRGSYT ASIYQNYMGN SFSGYSHSPP LLQVNRSSSN SPRTSETDDG VVGKSSDGED EQQVPKGPIH SPVELKHVHA TVVKVPEVNS SALPHKLRIK AKAMQIKVEA FDNEFEATQK LSSPIDMTSK RHFELEKHSA PSMVHSSLTP FSVQVTNIQD WSLKSEHWHQ KELSGKTQNS FKTGVVEMKD SGYKVSDPEN LYLKQGIANL SAEVVSLKRL IATQPISASD SG
Explore Nuclear factor interleukin-3-regulated protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets